The objective of Dorphan is the preclinical and clinical development of innovative therapeutic solutions for orphan and rare genetic diseases affecting mainly children, with a strong focus on two related lysosomal storage diseases, GM1-gangliosidosis and Morquio disease type B.


Chemin de l'Eglise 7, 1066 Epalinges, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business